Introduction
The rheumatic diseases (RD) play a disproportionately large role in the pathology of interstitial lung disease (ILD). This perception is not inconsequential, or without corroboration, as diffuse pulmonary disease in RD is estimated to be responsible for 1,600 deaths annually in the United States, a figure that corresponds to roughly 25% of all ILD deaths and 2% of deaths from all respiratory causes. 1 Nevertheless, most patients with RD do not present with or develop clinical pulmonary disease during the course of their systemic illness, a fact that puts pulmonary pathologists somewhat at odds with rheumatologists who often seem puzzled (and sometimes a little annoyed) by our invocation of "collagen vascular disease" as the underlying cause of many unexplained diffuse inflammatory and/or fibrotic processes identified in this organ and the adjacent pleura. To complicate matters further, it is well-recognized that a subset of RD present with lung disease before their joint, muscle, skin, and serological markers become diagnostic, 2 in fact, sometimes years in advance of recognizable systemic disease. 
Rheumatoid Arthritis (RA):

Radiologic Findings
A wide spectrum of radiologic findings are described in RA, including reticular opacities (with or without honeycombing), airway-associated abnormalities such as bronchiectasis and wall thickening, parenchymal nodules, and pleural effusions.
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Chronic damage to the small airways may occur rarely with scarring and loss (constrictive or obliterative bronchiolitis). 5 Ground glass opacities and reticular lines have a predilection for the periphery of the lung, with a bibasilar distribution (so-called "rheumatoid lung"). Honeycomb cysts may be seen in late stages of the disease, again, with a predilection for the peripheral lung bases.
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Pathologic Findings
Lung disease in RA encompasses a number of different histopathological patterns, 2, 7-11 with rheumatoid nodules being the most specific. When sudden respiratory failure occurs, terms such as "acute interstitial pneumonia" (AIP), 12 and "diffuse alveolar damage" (DAD) have been applied. 7 When fibrosis and honeycomb remodeling occur, the "usual interstitial pneumonia" (UIP)
histopathological pattern may be observed (i. 
Differential Diagnosis
Given the widespread use of immunomodulatory agents in the treatment of RA, when these patients develop pulmonary symptoms, biopsies are typically performed to exclude treatable lung infection or drug reaction (or both). The surgical lung biopsy in this context can be extremely difficult to interpret, given significant overlap in the morphologic patterns of drug reactions, infections, and the RD itself. Our approach is to perform special stains for organisms and to search for inflammatory changes that would not be characteristic for RA- 
Progressive Systemic Sclerosis (PSS)
Radiologic Findings
Bibasilar interstitial infiltrates are the typical radiologic findings in PSS-ILD.
The immediate subpleural lung is often spared and honeycombing is not common. 14, 15 The extent of ground glass attenuation in PSS-ILD is generally greater than that seen in idiopathic pulmonary fibrosis and reticular abnormalities tend to be less coarse. 16 Pulmonary hypertension may be evident. Pleural effusion and/or pleural thickening may occur as minor findings. Esophageal dilatation is frequent, and multi-focal consolidation or ground glass attenuation in the lower lobes may also occur with aspiration pneumonitis
Pathologic Findings
The pulmonary pathology of PSS-ILD can be distinctive, with the occurrence of bland paucicellular fibrosis accruing uniformly throughout the alveolar interstitium, with preservation of alveolar architecture. This distinctive "collagenization" of the lung interstitium has been confused with the pattern of lung fibrosis seen in idiopathic UIP 17 , although the uniform appearance of collagen deposition is more like that described for "group 3" NSIP, by Katzenstein and Fiorelli. 18 Nevertheless, in some cases, the "temporal heterogeneity" of the UIP pattern may be present, mainly characterized by advanced microscopic honeycomb remodeling. 19, 20 Pulmonary hypertensive changes may be present requiring careful examination of the pulmonary vasculature in the biopsy, since this is a major cause of mortality in PSS patients who develop lung disease. 21 Also, subclinical chronic aspiration should be carefully excluded as a co-morbid disease process, given the propensity of PSS patients to develop esophageal dysmotility. 22, 23 The OP and DAD patterns, which are not specific per se for PSS-ILD, can be observed. 24, 25 Rarely, alveolar hemorrhage with capillaritis can occur. 26 
Systemic Lupus Erythematosus (SLE)
Radiologic Findings
The chest radiologic manifestations of SLE are similar to those seen in other RD, and are characterized by variable ground glass attenuation, pleural thickening, pleural and pericardial effusions, and linear parenchymal opacities. [27] [28] [29] [30] [31] Acute pneumonitis typically produces more extensive changes of diffuse ground glass attenuation in the absence of architectural distortion but on rare occasions may be associated with a normal chest radiograph and HRCT. 32 Centrilobular nodules of ground glass attenuation also occur, particularly in the setting of pulmonary hemorrhage or vasculitis.
33
Pathologic Findings
Pulmonary disease in SLE occurs most often as one of 2 general categories of injury. The first is acute lupus pneumonitis (ALP). ALP is characterized by acute alveolitis with variable interstitial inflammation and edema. Hemosiderin-laden macrophages and capillaritis occur to variable extent and pleuritis is commonly present. 34, 35 When hemorrhage occurs in SLE, with or without hemoptysis, and sometimes with capillaritis), the process is referred to as "diffuse alveolar hemorrhage" (DAH) in SLE. Pulmonary hypertensive vascular disease can occur, including plexogenic and thrombotic lesions, and sometimes is the predominant feature of lung involvement. [36] [37] [38] [39] The second category of injury is characterized by a chronic cellular interstitial pneumonia (mainly lymphocytes and plasma cells), with variable interstitial fibrosis. 36 This latter NSIP pattern, is associated with a better prognosis than ALP. When pulmonary hemorrhage occurs, the prognosis may be adversely affected. 40 Pulmonary fibrosis occurs relatively infrequently in SLE. 34, 41, 42 LIP also is uncommon. 43, 44 Organizing pneumonia pattern is sometimes associated with SLE and can be the first manifestation of the disease. [45] [46] [47] Pulmonary amyloid deposition has been reported but is very rare. 
Polymyositis/ dermatomyositis (PM/DM)
Radiologic Findings
Radiologic abnormalities in PM/DM predominately effect the lung bases, similar to other RD. 3 Ikezoe and colleagues reviewed the HRCT findings in 23 patients with PM/DM who had HRCT abnormalities. 49 Ground glass opacities were seen in 92%, linear opacities in 92%, irregular interfaces in 88%, air-space consolidation in 52%, parenchymal micronodules in 28%, and honeycombing in 16%. As mentioned earlier, the most dramatic radiologic finding associated with PM/DM is the development of rapid onset of airspace consolidation. On biopsy, diffuse alveolar damage characterizes this clinical and radiological presentation. 
Sjögren Syndrome (SS)
Radiologic Findings
Mixed alveolar and interstitial infiltrates are characteristic in SS, often characterized by a finely reticular or nodular pattern. 62, 63 Patents with SS are at risk for the development of marginal zone B-cell lymphomas, and the occurrence of pleural effusion or hilar/mediastinal adenopathy should raise concern for lymphoma in these patients. 64 According to an HRCT study of 24 patients with SS by Lohrmann et al, thin walled cysts and small nodules occurred frequently (46.2%), possibly representing manifestations of lymphoid interstitial pneumonia (LIP), especially when accompanied by ground glass attenuation.
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Pathologic Findings
The typical surgical lung biopsy findings in SS include bronchiolitis, with or without airspace organization, follicular lymphoid hyperplasia along airways, diffuse NSIP or LIP pattern interstitial inflammation, and less frequently, interstitial fibrosis with a UIP-pattern. Small, non-necrotizing, granulomas, resembling those of hypersensitivity pneumonitis, are frequently identified in the interstitium when lymphoid infiltrates are prominent (LIP pattern) and in this setting cysts may be prominent. In a recent study of 15 patients by Parambil et al, the major lung findings were: NSIP in 5 patients, OP in 4, UIP in 3, LIP in 3, primary pulmonary lymphoma in 2, and diffuse interstitial amyloidosis in a single patient. 66 Another study of lung disease in SS found that NSIP was the predominant pattern in 20/33 patients (61%) 67 When dense lymphoid pulmonary infiltrates are encountered in SS, the possibility of lymphoma must be rigorously excluded by means of immunohistochemical (e.g. antibodies directed against cluster designation 20, cluster designation 43, kappa and lambda light chains) and molecular techniques (e.g. molecular hybridization in search of light and heavy chain restriction) applied to the biopsy specimen. Lymphoproliferative disorders, with or without amyloid deposition are well-described in SS, 64, [68] [69] [70] and non lymphoid lung malignancies such as carcinomas can also occur.
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